Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CA 19-9 antibody

CA 19-9 Reactivity: Human ELISA, FACS, IHC (p), IHC (fro), WB Host: Mouse Monoclonal 121SLE unconjugated
Catalog No. ABIN1042585
  • Target See all CA 19-9 Antibodies
    CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
    Reactivity
    • 34
    • 1
    • 1
    Human
    Host
    • 21
    • 15
    Mouse
    Clonality
    • 32
    • 3
    Monoclonal
    Conjugate
    • 19
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This CA 19-9 antibody is un-conjugated
    Application
    • 20
    • 15
    • 14
    • 12
    • 8
    • 4
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    ELISA, Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Western Blotting (WB)
    Purification
    IgM specific affinity chromatography
    Immunogen
    Ten precipitin lines obtained after immunodiffusion using monoclonal antibody NS 19-9 and mucins isolated from an ovarian cyst of a OLe (a+b-) patient
    Clone
    121SLE
    Isotype
    IgM
    Top Product
    Discover our top product CA 19-9 Primary Antibody
  • Application Notes
    Optimal antibody dilution should be determined by titration, however as a guideline try at 2 μg/mL on FFPE tissue
    Comment

    Myeloma, fusion partners: Spleen cells from immunised BALB/c mice were fused with cells of the Sp2/0 myeloma line

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    Purified antibody in phosphate buffered saline containing 10 mM sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Partyka, Maupin, Brand, Haab: "Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation." in: Proteomics, Vol. 12, Issue 13, pp. 2212-20, (2012) (PubMed).

    Schnegelsberg, Schumacher, Valentiner: "Lectin histochemistry of metastasizing and non-metastasizing breast and colon cancer cells." in: Anticancer research, Vol. 31, Issue 5, pp. 1589-97, (2011) (PubMed).

    Shi, Gao, Wang, Wang, Tian, Zhu, Shen, Qin: "CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity." in: World journal of gastroenterology : WJG, Vol. 17, Issue 24, pp. 2965-71, (2011) (PubMed).

    Köhler, Ullrich, Richter, Schumacher: "E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung." in: British journal of cancer, Vol. 102, Issue 3, pp. 602-9, (2010) (PubMed).

    Rye, Bovin, Vlasova, Molodyk, Baryshnikov, Kreutz, Garinther, Schultes, Noujaim, Madiyalakan, Magnani, Nilsson, Nilsson, Nustad, Norum, Bell, Cao, Suresh, Very, Freeman, Yeung, Hilgers: "Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997." in: Tumour biology, Vol. 19, Issue 5, pp. 390-420, (1998) (PubMed).

    Bara, Mollicone, Herrero-Zabaleta, Gautier, Daher, Oriol: "Ectopic expression of the Y (Ley) antigen defined by monoclonal antibody 12-4LE in distal colonic adenocarcinomas." in: International journal of cancer. Journal international du cancer, Vol. 41, Issue 5, pp. 683-9, (1988) (PubMed).

  • Target
    CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
    Alternative Name
    CA19-9    (CA 19-9 Products)
    Background
    Synonyms:
    Sialyl Lewis (a) antibody,Sialyl Lewis(a) antibody,Sialyl Lewisa antibody
You are here:
Support